
Subcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection
Aug 20, 2026 - 00:11:37
Radio and PodcastLive Radio & Podcasts
No Label: Geoff Kerchner Dr. Geoff Kerchner, Vice President and Global Head of Neurodegeneration at Roche, Basel, Switzerland, discusses the science behind PrevenTRON, a prevention study evaluating trontinemab in individ...